Skip to main content
. 2021 Apr 24;139:104847. doi: 10.1016/j.jcv.2021.104847

Fig. 1.

Fig 1

Demographic information on validation cohort (n=296). (a) Age distribution of COVID-19 patients in the validation cohort (global and by type of therapy). (b) BMI distribution. (c) Proportion of males and females: The ICU group comprised more male, the outpatient group more female individuals (p<0.001).